Stryker (NYSE: SYK) executive granted 14,912 performance-based shares

Rhea-AI Filing Summary

Pierce James Andrew reported acquisition or exercise transactions in this Form 4 filing.

Stryker Corp Group President James Andrew Pierce reported an equity award of 14,912 shares of Common Stock. The shares were granted at no cash cost upon achievement of pre-set three-year earnings per share and sales goals and will vest on March 21, 2026.

After this grant, Pierce directly holds 88,246 common shares. He also reports indirect holdings of 712 shares held by "Son GP", 713 shares held by "Son AP", and 1,595 shares held through a 401(k) account as of the same date.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Pierce James Andrew

(Last) (First) (Middle)

1941 STRYKER WAY

(Street)

PORTAGE MI 49002

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
STRYKER CORP [ SYK ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group President

3. Date of Earliest Transaction (Month/Day/Year)
03/09/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/09/2026		A(1)		14,912	A	$0	88,246	D
Common Stock								712	I	By Son GP
Common Stock								713	I	By Son AP
Common Stock								1,595	I	By 401K

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Acquired upon the achievement of pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. The earned shares vest on March 21, 2026.

Remarks:

	/s/ Austin Y. Ke, attorney-in-fact for James Andrew Pierce	03/11/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Stryker (SYK) executive James Andrew Pierce report on this Form 4?

James Andrew Pierce, a Group President at Stryker, reported an award of 14,912 shares of Common Stock. The shares were granted for meeting three-year performance goals and will vest on March 21, 2026, increasing his reported direct holdings to 88,246 shares.

Is the Stryker (SYK) Form 4 transaction a market purchase or sale?

The Form 4 shows an acquisition coded as a grant or award, not a market trade. Pierce received 14,912 shares at zero price per share after meeting performance targets, so it is compensation-related rather than an open-market buy or sell transaction.

When do James Andrew Pierce’s newly awarded Stryker (SYK) shares vest?

The earned 14,912 performance-based Stryker shares vest on March 21, 2026. They were awarded after achieving pre-established three-year adjusted diluted net earnings per share and sales performance goals, meaning Pierce must wait until that vesting date for full ownership of the shares.

How many Stryker (SYK) shares does James Andrew Pierce hold after this award?

Following the grant, Pierce directly holds 88,246 Stryker common shares. He also reports indirect ownership of 712 shares held by “Son GP”, 713 shares held by “Son AP”, and 1,595 shares held through a 401(k) plan, all as of the transaction date.

What performance conditions were tied to the Stryker (SYK) share award?

The 14,912-share award was earned upon achieving pre-established three-year adjusted diluted net earnings per share goals and sales performance goals. These conditions link executive compensation to Stryker’s longer-term financial and revenue performance before the shares vest on March 21, 2026.

Does the Stryker (SYK) Form 4 show any stock option exercises or sales?

The disclosed data show no option exercises or open-market sales. The only transaction is a grant or award of 14,912 common shares, with additional entries simply updating indirect holdings for family-related accounts and a 401(k) plan rather than recording new market trades.